Bruker Corporation is a medical devices business based in the US. Bruker Corporation shares (BRKR) are listed on the NASDAQ and all prices are listed in US Dollars. Bruker Corporation employs 9,707 staff and has a trailing 12-month revenue of around $3 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $63.06 |
|---|---|
| 52-week range | $53.68 - $94.79 |
| 50-day moving average | $67.64 |
| 200-day moving average | $72.52 |
| Wall St. target price | $77.91 |
| PE ratio | 22.6703 |
| Dividend yield | $0.2 (0.32%) |
| Earnings per share (TTM) | $2.73 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $63.06 from 2024-07-22
| 1 week (2024-07-16) | -4.82% |
|---|---|
| 1 month (2024-06-21) | -4.48% |
| 3 months (2024-04-23) | -23.53% |
| 6 months (2024-01-23) | -12.33% |
| 1 year (2023-07-21) | -16.33% |
|---|---|
| 2 years (2022-07-22) | -2.52% |
| 3 years (2021-07-23) | 82.35 |
| 5 years (2019-07-23) | 29.74% |
Valuing Bruker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bruker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bruker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, Bruker Corporation shares trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Bruker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.64. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bruker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Bruker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $561.9 million.
The EBITDA is a measure of a Bruker Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $3 billion |
|---|---|
| Operating margin TTM | 11% |
| Gross profit TTM | $1.3 billion |
| Return on assets TTM | 6.61% |
| Return on equity TTM | 30.29% |
| Profit margin | 13.38% |
| Book value | $9.74 |
| Market Capitalization | $9.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 7.78% of net profits
Recently Bruker Corporation has paid out, on average, around 7.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.32% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bruker Corporation shareholders could enjoy a 0.32% return on their shares, in the form of dividend payments. In Bruker Corporation's case, that would currently equate to about $0.2 per share.
While Bruker Corporation's payout ratio might seem low, this can signify that Bruker Corporation is investing more in its future growth.
Bruker Corporation's most recent dividend payout was on 16 June 2024. The latest dividend was paid out to all shareholders who bought their shares by 2 June 2024 (the "ex-dividend date").
Over the last 12 months, Bruker Corporation's shares have ranged in value from as little as $53.6767 up to $94.7875. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bruker Corporation's is 1.197. This would suggest that Bruker Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts. .
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
A deep dive into the highlights and limitations of Frec.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.